BIGBEAR
PHARMACEUTICAL
Selumetinib inhibits the activity of MEK1/2 proteins, blocks the RAS/RAF/MEK/ERK signaling pathway, and thereby suppresses the proliferation and survival of tumor cells.
AuthenticGuaranteeFast DeliveryPrivacy How to Use Selumetinib (Koselugo)Selumetinib (Koselugo) is a kinase inhibitor specifically used to treat symptomatic, unresectable plexiform neurofibr···【More】
Update: 18 Mar,2026Source: BigbearViews: 93
Precautions for Selumetinib UseSelumetinib was approved by the U.S. Food and Drug Administration (FDA) on April 10, 2020, under the brand name Koselug···【More】
Update: 18 Mar,2026Source: BigbearViews: 92
Selumetinib's Efficacy and FunctionsDeveloped by AstraZeneca in the UK, selumetinib was officially approved for marketing in China in May 2023 and···【More】
Update: 18 Mar,2026Source: BigbearViews: 88
Main Actions of SelumetinibInhibit Tumor GrowthBy inhibiting vascular endothelial growth factor receptors, it reduces tumor angiogenesis and blocks tu···【More】
Update: 11 Mar,2026Source: BigbearViews: 89
Overview of SelumetinibSelumetinib sulfate capsules are an oral MEK inhibitor indicated for the treatment of inoperable plexiform neurofibromas associ···【More】
Update: 11 Mar,2026Source: BigbearViews: 86
Drug Interactions of SelumetinibConcomitant Medications That Are ContraindicatedConcomitant use with the following drugs is prohibited:Strong metaboli···【More】
Update: 11 Mar,2026Source: BigbearViews: 87
Therapeutic EffectsSelumetinib is a targeted therapeutic agent for tumor cells, with its main active ingredient being a selective inhibitor of mitogen···【More】
Update: 11 Mar,2026Source: BigbearViews: 87
In addition to its expected therapeutic effects, selumetinib may cause some adverse reactions. While not all side effects will occur, medical interven···【More】
Update: 10 Mar,2026Source: BigbearViews: 89
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos
